| Original language | English (US) |
|---|---|
| Pages (from-to) | 2112-2115 |
| Number of pages | 4 |
| Journal | Leukemia |
| Volume | 28 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2014 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition. / Gordon, G. W.; Monge, J.; Channon, M. B. et al.
In: Leukemia, Vol. 28, No. 10, 01.10.2014, p. 2112-2115.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition
AU - Gordon, G. W.
AU - Monge, J.
AU - Channon, M. B.
AU - Wu, Q.
AU - Skulan, J. L.
AU - Anbar, A. D.
AU - Fonseca, R.
N1 - Funding Information: This work was funded by an ASU-Mayo Clinic Seed Grant. Dr Fonseca is a Clinical Investigator of the Damon Runyon Cancer Research Fund. His work is supported by grants R01 CA83724, ECOG CA 21115T, Predolin Foundation, Mayo Clinic Cancer Center and the Mayo Foundation. The authors thank Dr Jennifer Morgan for catalyzing the collaboration between Dr Fonseca and the ASU team. The work of Drs Anbar, Gordon, and Skulan was partially supported by NASA Human Research Program Grants NNX08AQ36G and 12-12_NASA_2-0046. Dr Channon’s work was supported by the Bisgrove Scholars Program of Science Foundation Arizona. This work was funded in part by Arizona’s Technology Research Initiative Fund, a voter-approved program that is supported by state sales tax and administered through the Arizona Board of Regents. Dr Anbar thanks Dr Michael Anbar for inspiring him to pursue the use of natural isotope variations in clinical medicine. Funding Information: This project was funded by the Calsberg Foundation, the Novo Nordic Research Foundation, the Lundbeck Foundation, the Danish Research Council (FSS under Det Frie Forskningsråd), the Danish Cancer Society (Kræftens Bekæmpelse) and Dansk Kræftforsknings Fond. JB was funded from a grant from the Danish Strategic Research Council rewarded to M Givskov. We thank K Kaltoft for the gift of the MyLa2059 cell line.
PY - 2014/10/1
Y1 - 2014/10/1
UR - http://www.scopus.com/inward/record.url?scp=84921712811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921712811&partnerID=8YFLogxK
U2 - 10.1038/leu.2014.193
DO - 10.1038/leu.2014.193
M3 - Letter
C2 - 24919808
AN - SCOPUS:84921712811
SN - 0887-6924
VL - 28
SP - 2112
EP - 2115
JO - Leukemia
JF - Leukemia
IS - 10
ER -